These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
672 related articles for article (PubMed ID: 11532942)
21. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
22. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366 [TBL] [Abstract][Full Text] [Related]
23. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650 [TBL] [Abstract][Full Text] [Related]
24. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond. Nie J; Pei D Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471 [TBL] [Abstract][Full Text] [Related]
25. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. Wang F; Reierstad S; Fishman DA Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136 [TBL] [Abstract][Full Text] [Related]
26. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Suenaga N; Mori H; Itoh Y; Seiki M Oncogene; 2005 Jan; 24(5):859-68. PubMed ID: 15558018 [TBL] [Abstract][Full Text] [Related]
27. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation. Park JM; Kim A; Oh JH; Chung AS Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627 [TBL] [Abstract][Full Text] [Related]
28. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells. Wang C; Chen Z; Li Z; Cen J Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666 [TBL] [Abstract][Full Text] [Related]
29. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation. Stack MS; Itoh Y; Young TN; Nagase H Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767 [TBL] [Abstract][Full Text] [Related]
30. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284 [TBL] [Abstract][Full Text] [Related]
31. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952 [TBL] [Abstract][Full Text] [Related]
32. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2. Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156 [TBL] [Abstract][Full Text] [Related]
33. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Fishman DA; Bafetti LM; Stack MS Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550 [TBL] [Abstract][Full Text] [Related]
34. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. Mori H; Tomari T; Koshikawa N; Kajita M; Itoh Y; Sato H; Tojo H; Yana I; Seiki M EMBO J; 2002 Aug; 21(15):3949-59. PubMed ID: 12145196 [TBL] [Abstract][Full Text] [Related]
36. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells. Maquoi E; Frankenne F; Noël A; Krell HW; Grams F; Foidart JM Exp Cell Res; 2000 Dec; 261(2):348-59. PubMed ID: 11112341 [TBL] [Abstract][Full Text] [Related]
37. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Jo M; Thomas LE; Wheeler SE; Curry TE Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206 [TBL] [Abstract][Full Text] [Related]
38. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414 [TBL] [Abstract][Full Text] [Related]
39. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378 [TBL] [Abstract][Full Text] [Related]
40. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]